FDA applicant
Poonglim Pharmatech, Inc.
FDA records 6 decisions for Poonglim Pharmatech, Inc. (Gunsan, KR) from 2018 to 2024: 6 510(k) clearances. Most are in product codes QNQ (Low Dead Space Piston Syringe) and FMI (Needle, Hypodermic, Single Lumen). Since 2016 its 510(k)s took a median of 270 days from receipt to decision, against 182 for FDA’s reviews in the same codes and years. Its devices cite 7 predicates, 5 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Poonglim Pharmatech, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2024
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2018.
Planning a device like Poonglim Pharmatech, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report